Portfolio company
Motley Bio
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops multi-omic sequencing technology for disease detection and drug discovery services for biotechnology and pharmaceutical firms.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Romix Bio
This company develops a molecular scan platform using cell-free RNA liquid biopsy and artificial intelligence for disease profiling and drug development for biotechnology customers.
Cellanome
This company develops a multi-omics platform that integrates imaging and sequencing for single-cell analysis to serve biotechnology researchers and drug developers.
Foundational Bio
This company provides automated sequencing and laboratory services using robotic systems for life science researchers and medical institutions.
QuirieGen
This company develops single-cell multi-omic technologies and AI models for drug discovery and development within the pharmaceutical sector.
OMIC
This life science technology company develops next-generation sequencing and multiomics platforms for researchers and clinicians to advance science and medicine.
Mission Bio
This company develops single-cell multi-omics analysis platforms for researchers and clinicians to enable precision medicine and drug development.
BioSkryb
This company develops genomic amplification and sequencing systems for researchers and clinicians to analyse DNA and RNA from single cells.
Multiomic Health
This company develops an artificial intelligence platform for discovering precision medicines and biomarkers for patients with metabolic syndrome-related chronic diseases.